About
Biography
I am a clinical fellow specializing in pediatric infectious diseases. I strive to provide thoughtful, evidence-based care. My goal is to balance the best available science with the unique needs of each child and family. As a pediatric infectious disease specialist, I diagnose and treat complex infections. I aim to ensure that medications and diagnostic tests treat infections without causing harm.
I have always been curious about science, have a passion for problem-solving and a desire to make a meaningful impact. I chose pediatrics as we can fix most pediatric conditions, especially infections. As an infectious diseases doctor, my goal is to improve the life of every child I see.
I value the physician-child-patient relationship and am honored by the trust parents place in us when we care for their kids. I believe in open communication and partnering with families. I explain medical decisions so that parents feel informed and empowered in their child’s care.
My research aims to improve the sharing and availability of medical knowledge. We store a lot of important information in the electronic medical record (EMR), but accessing this information to improve patient care is challenging. I want to make it easier to use the information we collect to improve our ability to choose better medications for kids.
When I am not at work, I enjoy going for a long run or bike ride. I like to cook and try new foods, especially while traveling with my wife. I also like to fix and improve things around the house.
BS: University of Pittsburgh, Pittsburgh, PA,
MD: Vanderbilt University School of Medicine, Nashville, TN,
Residency: Cincinnati Children's Hospital Medical Center, Cincinnati, OH,
Interests
Pediatric infectious diseases; clinical informatics
Services and Specialties
Interests
Pediatric infectious diseases; clinical informatics
Publications
Real-world performance of Aspergillus and Mucorales Polymerase Chain Reaction Assays on Bronchoalveolar Lavage Fluid in Immunocompromised Children and Young Adults. Journal of the Pediatric Infectious Diseases Society. 2026.
Emapalumab for Maladaptive Interferon-γ-Mediated Inflammation in Drug Reaction With Eosinophilia and Systemic Symptoms Complicating First-Line Antituberculosis Therapy. Pediatric Blood and Cancer. 2025; 72(12):e32052.
Enterohepatic Non-H. pylori Helicobacter Infection in a Patient With X-Linked Agammaglobulinemia. Pediatric Dermatology. 2025.
Polymerase chain reaction fails to detect mixed malaria infections in siblings from Ethiopia. Journal of Infection and Chemotherapy. 2025; 31(9):102777.
Clinical Impact of Bronchoalveolar Lavage in Pediatric and Young Adult Patients With Cancer and Suspected Respiratory Infections. Journal of the Pediatric Infectious Diseases Society. 2025; 14(1).
Disseminated Disease After Candidemia in Children and Young Adults: Epidemiology, Diagnostic Evaluation and Risk Factors. Pediatric Infectious Disease Journal. 2024; 43(4):328-332.
A comprehensive assessment of the prolonged febrile neutropenia evaluation in pediatric oncology patients. Pediatric Blood and Cancer. 2024; 71(3):e30818.
Impact of Time-to-Antibiotic Delivery in Pediatric Patients With Cancer Presenting With Febrile Neutropenia. JCO Oncology Practice. 2024; 20(2):228-238.
1702. Disseminated Candidiasis after Candidemia: Epidemiology, Diagnostic Evaluation, and Risk Factors. Open Forum Infectious Diseases. 2023; 10(Supplement_2):ofad500.1535.
Ultrasound and Microbubble-targeted Delivery of a microRNA Inhibitor to the Heart Suppresses Cardiac Hypertrophy and Preserves Cardiac Function. Theranostics. 2019; 9(23):7088-7098.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2025 Cincinnati Children's Hospital Medical Center. All rights reserved.
